missing translation for 'onlineSavingsMsg'
Learn More

R&D Systems™ CY 09

Codice prodotto. 18791108
Cambia vista
Click to view available options
Quantità:
10 mg
50 mg
Dimensione della confezione:
10mg
50mg
2 product options available for selection
Product selection table with 2 available options. Use arrow keys to navigate and Enter or Space to select.
Codice prodotto. Quantità Dimensione della confezione
18791108 50 mg 50mg
18783198 10 mg 10mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 2 options available.
2 options
Les retours ne sont pas autorisés pour ce produit. Consulta la politica di reso
Codice prodotto. 18791108 Fornitore R&D Systems™ N. del fornitore 6436/50
 Articolo soggetto a restrizioni
Spedizione stimata: 27-11-2026
Aggiungi al carrello
Aggiungi al carrello

missing translation for 'validMainframeMsg'

Les retours ne sont pas autorisés pour ce produit. Consulta la politica di reso

A Tocris product, part of R&D Systems. Inflammasomes Inhibitors

CY 09 is a NLRP3 inhibitor (Kd = 500 nM); directly binds to ATP-binding motif of NLRP3 NACHT domain. Blocks NLRP3 inflammasome assembly and activation. Displays therapeutic effects on mouse models of cryopyrin-associated autoinflammatory syndrome (CAPS) and type 2 diabetes. Exhibits no activity for hERG (10 μM).
TRUSTED_SUSTAINABILITY

Specifica

Materiale o nome chimico 4-[[4-Oxo-2-thioxo-3-[[3-(trifluoromethyl)phenyl]methyl]-5-thiazolidinylidene]methyl]benzoic acid
CAS 1073612-91-5
Quantità 50 mg
Linea di prodotti Tocris
Formula molecolare C19H12F3NO3S2
Purezza 98%
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.